FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115633265> ?p ?o ?g. }

• W2115633265 endingPage "499" @default.
• W2115633265 startingPage "491" @default.
• W2115633265 abstract "Background. We sought to quantify the survival benefits attributable to antiretroviral therapy (ART) in South Africa since 2004. Methods. We used the Cost-Effectiveness of Preventing AIDS Complications–International model (CEPAC) to simulate 8 cohorts of human immunodeficiency virus (HIV)–infected patients initiating ART each year during 2004–2011. Model inputs included cohort-specific mean CD4+ T-cell count at ART initiation (112–178 cells/µL), 24-week ART suppressive efficacy (78%), second-line ART availability (2.4% of ART recipients), and cohort-specific 36-month retention rate (55%–71%). CEPAC simulated survival twice for each cohort, once with and once without ART. The sum of the products of per capita survival differences and the total numbers of persons initiating ART for each cohort yielded the total survival benefits. Results. Lifetime per capita survival benefits ranged from 9.3 to 10.2 life-years across the 8 cohorts. Total estimated population lifetime survival benefit for all persons starting ART during 2004–2011 was 21.7 million life-years, of which 2.8 million life-years (12.7%) had been realized by December 2012. By 2030, benefits reached 17.9 million life-years under current policies, 21.7 million life-years with universal second-line ART, 23.3 million life-years with increased linkage to care of eligible untreated patients, and 28.0 million life-years with both linkage to care and universal second-line ART. Conclusions. We found dramatic past and potential future survival benefits attributable to ART, justifying international support of ART rollout in South Africa." @default.
• W2115633265 created "2016-06-24" @default.
• W2115633265 creator A5002686651 @default.
• W2115633265 creator A5003846354 @default.
• W2115633265 creator A5011959471 @default.
• W2115633265 creator A5019522183 @default.
• W2115633265 creator A5024120430 @default.
• W2115633265 creator A5032104701 @default.
• W2115633265 creator A5062889731 @default.
• W2115633265 creator A5074313423 @default.
• W2115633265 date "2013-12-03" @default.
• W2115633265 modified "2023-09-26" @default.
• W2115633265 title "The Survival Benefits of Antiretroviral Therapy in South Africa" @default.
• W2115633265 cites W1531725059 @default.
• W2115633265 cites W1539475119 @default.
• W2115633265 cites W1717206243 @default.
• W2115633265 cites W1767940945 @default.
• W2115633265 cites W1967223378 @default.
• W2115633265 cites W1972486019 @default.
• W2115633265 cites W1983901054 @default.
• W2115633265 cites W2012477550 @default.
• W2115633265 cites W2016854787 @default.
• W2115633265 cites W2017793579 @default.
• W2115633265 cites W2018799025 @default.
• W2115633265 cites W2031368727 @default.
• W2115633265 cites W2041148769 @default.
• W2115633265 cites W2051727386 @default.
• W2115633265 cites W2063420196 @default.
• W2115633265 cites W2065464437 @default.
• W2115633265 cites W2079766092 @default.
• W2115633265 cites W2088008322 @default.
• W2115633265 cites W2091471337 @default.
• W2115633265 cites W2092929619 @default.
• W2115633265 cites W2096254883 @default.
• W2115633265 cites W2103200641 @default.
• W2115633265 cites W2108259145 @default.
• W2115633265 cites W2110937893 @default.
• W2115633265 cites W2111642044 @default.
• W2115633265 cites W2120293408 @default.
• W2115633265 cites W2120637537 @default.
• W2115633265 cites W2136683144 @default.
• W2115633265 cites W2139894829 @default.
• W2115633265 cites W2141277445 @default.
• W2115633265 cites W2145352823 @default.
• W2115633265 cites W2165557071 @default.
• W2115633265 cites W2171141994 @default.
• W2115633265 doi "https://doi.org/10.1093/infdis/jit584" @default.
• W2115633265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3903379" @default.
• W2115633265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24307741" @default.
• W2115633265 hasPublicationYear "2013" @default.
• W2115633265 type Work @default.
• W2115633265 sameAs 2115633265 @default.
• W2115633265 citedByCount "33" @default.
• W2115633265 countsByYear W21156332652013 @default.
• W2115633265 countsByYear W21156332652014 @default.
• W2115633265 countsByYear W21156332652015 @default.
• W2115633265 countsByYear W21156332652016 @default.
• W2115633265 countsByYear W21156332652017 @default.
• W2115633265 countsByYear W21156332652018 @default.
• W2115633265 countsByYear W21156332652019 @default.
• W2115633265 countsByYear W21156332652021 @default.
• W2115633265 countsByYear W21156332652022 @default.
• W2115633265 countsByYear W21156332652023 @default.
• W2115633265 crossrefType "journal-article" @default.
• W2115633265 hasAuthorship W2115633265A5002686651 @default.
• W2115633265 hasAuthorship W2115633265A5003846354 @default.
• W2115633265 hasAuthorship W2115633265A5011959471 @default.
• W2115633265 hasAuthorship W2115633265A5019522183 @default.
• W2115633265 hasAuthorship W2115633265A5024120430 @default.
• W2115633265 hasAuthorship W2115633265A5032104701 @default.
• W2115633265 hasAuthorship W2115633265A5062889731 @default.
• W2115633265 hasAuthorship W2115633265A5074313423 @default.
• W2115633265 hasBestOaLocation W21156332651 @default.
• W2115633265 hasConcept C126322002 @default.
• W2115633265 hasConcept C127598652 @default.
• W2115633265 hasConcept C142462285 @default.
• W2115633265 hasConcept C144024400 @default.
• W2115633265 hasConcept C149923435 @default.
• W2115633265 hasConcept C201903717 @default.
• W2115633265 hasConcept C2908647359 @default.
• W2115633265 hasConcept C2993143319 @default.
• W2115633265 hasConcept C3013748606 @default.
• W2115633265 hasConcept C512399662 @default.
• W2115633265 hasConcept C71924100 @default.
• W2115633265 hasConcept C72563966 @default.
• W2115633265 hasConcept C74909509 @default.
• W2115633265 hasConcept C99454951 @default.
• W2115633265 hasConceptScore W2115633265C126322002 @default.
• W2115633265 hasConceptScore W2115633265C127598652 @default.
• W2115633265 hasConceptScore W2115633265C142462285 @default.
• W2115633265 hasConceptScore W2115633265C144024400 @default.
• W2115633265 hasConceptScore W2115633265C149923435 @default.
• W2115633265 hasConceptScore W2115633265C201903717 @default.
• W2115633265 hasConceptScore W2115633265C2908647359 @default.
• W2115633265 hasConceptScore W2115633265C2993143319 @default.
• W2115633265 hasConceptScore W2115633265C3013748606 @default.
• W2115633265 hasConceptScore W2115633265C512399662 @default.
• W2115633265 hasConceptScore W2115633265C71924100 @default.

• next